Friday, May 2nd, 2025

Chularat Hospital: Poised for Strong 4Q24 with Higher Revenue per Adjusted RW

Date of Report: October 1, 2024
Broker: CGS-CIMB Securities Malaysia Sdn. Bhd.

Company Overview

Chularat Hospital is a Thailand-based healthcare provider offering a wide range of medical services. The hospital group operates multiple facilities and serves a broad patient base, focusing on delivering quality healthcare services in the region.

Financial Performance

Chularat Hospital is expected to perform well in 4Q24, with anticipated revenue of THB7,200 per adjusted RW (Relative Weight), reflecting strong operational efficiency and an increase in patient volume. The hospital’s financial outlook is promising, driven by improvements in both patient inflow and service offerings.

Revenue Drivers

The revenue growth for Chularat Hospital in the fourth quarter is largely attributed to a rise in the adjusted RW metric. This increase indicates the hospital’s ability to generate higher revenue per patient, which is a positive indicator of the company’s financial health and profitability.

Investment Recommendation

The report maintains an “Add” recommendation for Chularat Hospital, with an increased target price (TP) of THB3.10. The positive outlook is supported by the hospital’s consistent ability to enhance revenue per adjusted RW and its growing patient base, both of which signal long-term growth potential.

Conclusion

Chularat Hospital is poised for a strong 4Q24 performance, with a notable increase in revenue per adjusted RW. This growth, coupled with the hospital’s strong operational framework, supports the “Add” recommendation and revised higher target price of THB3.10. The company’s steady expansion and financial health make it a compelling investment in the healthcare sector.

“ST Engineering 2025 Outlook: Strong Growth Drivers, Record-High Order Book & ESG Leadership”

Executive Summary This comprehensive report provides a detailed look into ST Engineering, a leading conglomerate in Singapore that is transforming its business through strategic focus on its high‐growth segments: Commercial Aerospace, Urban Solutions &...

Vale Nears $18 Billion Settlement for 2015 Dam Disaster Reparations

Date of Report: September 17, 2024Broker: Refinitiv, London Stock Exchange Group (LSEG) Ongoing Negotiations for $18 Billion Settlement Vale is in advanced discussions with the Brazilian government regarding a potential $18 billion settlement tied...

Contemporary Amperex Technology (300750 CH): Navigating Market Challenges with Strong Q3 Performance and Future Growth Prospects

Date of Report October 21, 2024 Broker UOB Kay Hian Company Overview Contemporary Amperex Technology (300750 CH) is a Chinese battery manufacturer and technology company specializing in the production of lithium-ion batteries for electric...